The multi-resistant neuroblastoma cell line SK-N-BE(2), isolated from a patient with recurrent stage 4 neuroblastoma, was chosen for further analysis, since this was one of the few cell lines that was viable after PPM1D shRNA knockdown. Here, PPM1D is linked to neuroblastoma.